We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Heikki Joensuu

Heikki Joensuu MD, PhD

Research Professor, Academy of Finland; Director, Laboratory of Molecular Oncology, Biomedicum, Helsinki, Finland

Dr. Heikki Joensuu is a specialist in medical oncology.  He was nominated as the Professor of Oncology, Helsinki University, Helsinki, Finland, in 1994, and acted as the Physician-in-Chief and Medical Director of the Department of Oncology, Helsinki University Central Hospital in 1994 to 2009. He was elected as Research Professor of Academy of Finland in 2009, which is his current position.  He is the Director of the Laboratory of Molecular Oncology, Biomedicum, Helsinki.  Professor Joensuu has acted as the Principal Investigator in several collaborative group studies. He is a Fellow of the European Academy of Cancer Sciences.

Recent Contributions to PracticeUpdate:

  1. Risk for Recurrence of GIST After Adjuvant Imatinib